mibefradil has been researched along with lacidipine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, TJ; Cao, Z; Cooper, ME; Hulthén, UL | 1 |
Budihna, MV; Drevensek, G; Martinuc, J | 1 |
Arh, M; Budihna, MV | 1 |
3 other study(ies) available for mibefradil and lacidipine
Article | Year |
---|---|
Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Diabetes Mellitus, Experimental; Dihydropyridines; Hypertrophy; Male; Mesenteric Arteries; Mibefradil; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Ramipril; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes | 1998 |
Action of mibefradil and lacidipine on the isolated human anterior tibial artery.
Topics: Calcium Channel Blockers; Dihydropyridines; Humans; In Vitro Techniques; Mibefradil; Osmolar Concentration; Potassium Chloride; Tibial Arteries; Vasoconstriction; Vasoconstrictor Agents | 2000 |
Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Mibefradil; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitrendipine; Pressure; Rats; Rats, Wistar; Reference Values; Ventricular Function, Left | 2000 |